<![CDATA[CELGENE 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=28647>Thu, 14 May 2026 10:27:39 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[REVLIMID® (Lenalidomide) Approved by the European Commission as Monotherapy for the Maintenance Treatment of Patients with Newly Diagnosed Multiple Myeloma after Autologous Stem Cell Transplantation]]>https://www.newswire.co.kr/newsRead.php?no=845765Mon, 27 Feb 2017 09:45:33 +0900